StockTipsArenaBeta

BUY Divi's Laboratories Limited — Jatin Gedia, TM Investment Technologies

BUYDivi's Laboratories Limited
Divi's Laboratories share price target & all analyst calls

byJatin Gedia, TM Investment TechnologiesHorizon: NA (inferred Swing (≤2wk))5 Nov 2026via NDTV Profit

Entry₹10,142.5Inferred
Target₹10,800
Total upside +6.48%
Stop loss₹9,500-6.33% risk
CMP₹10,320.51d ago
Active+1.75%+4.65%upside left 12d left
Follow Jatin Gedia for new calls(21% target hit, 47 closed calls)Get alertsWatch DIVISLAB for new buy/sell callsGet alertsSee 2 other Swing calls on DIVISLABSee 203 other Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 7 Nov, 5:24 pm IST
3 supporting2 neutral1 opposing
Supports the BUY call (3)

Divi's Laboratories Q2 Results: Net Profit Jumps 64% To Rs 1,127 Crore, Revenue Rises 35%; Margins Expand

NewsNdtv-Profit·7 Nov · today

(opens in new tab)

MACD above its signal line — bullish momentum

Technicals · macd·7 Nov · today

2 other SEBI-registered advisors have active swing BUY calls on this stock, all issued in the last 14 days

Advisor consensus · same horizon·30 Oct · 1w ago

Neutral / worth noting (2)

Divi's Laboratories Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.

NSE · Outcome of Board Meeting·7 Nov · today

(opens in new tab)

Q2 FY27 results scheduled — board meets 07 Nov 2026

BSE · Board Meeting·7 Nov · today

(opens in new tab)
Weighs against the BUY call (1)

RSI at 82 — overbought territory

Technicals · rsi·7 Nov · today

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Divi's Laboratories

All analyst calls on Divi's Laboratories

More from Jatin Gedia, TM Investment Technologies

Every call and its outcome